- Home
- » Tags
- » Lercanidipine
Top View
- Medicines and Falls Risk in Care Homes Commonly Prescribed Drugs That Can Contribute to Falls
- Interactions with Experimental COVID-19 Therapies
- Package Leaflet: Information for the <Patient> <User>
- Medicines and Falls in Hospital
- Neemmc Guidelines for Tablet Crushing and Administration Via Enteral Feeding Tubes
- A Comparative Review of the SAR of Amlodipine and Lercanidipine
- Guideline on Medication and the Risk of Falling
- Cost Comparison Charts
- Pregabalin Lercanidipine Hydrochloride Ulipristal Acetate
- An Inventory of Medicinal Products Causing Skin Rash: Clinical and Regulatory Lessons
- LERCANIDIPINE SANDOZ Lercanidipine Hydrochloride Consumer Medicine Information
- 20 Mg/10 Mg Film-Coated Tablets Enalapril Maleate/Lercanidipine Hydrochloride
- EN PIL Lercanidipin
- Drug-Induced Hyperpigmentation: Review and Case Series
- Calcium Channel Blockers, Postural Vasoconstriction and Dependent Oedema in Essential Hypertension
- The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- 01 Stockley's Herbal Medicines Interactions PRELIMS 1
- VI.2 Elements for a Public Summary
- Adverse Effects of Interactions Between Antidepressants and Medications Used in Treatment of Cardiovascular Disorders
- LERCANIDIPINE SANDOZ Lercanidipine Hydrochloride Consumer Medicine Information
- Formulation Development and Invitro Evaluation Of
- Efficacy and Tolerability of Lercanidipine in Mild to Moderate Hypertension Among Asians of Different Ethnic Groups Chia Y C, Yeoh E S H, Ng C J, Khoo E M, Chua C T
- Package Leaflet: Information for the User
- Lercanidipine Hydrochloride and Losartan Potassium Compound Preparation and Preparation Method Thereof
- Interactions with PBC Agents
- Supplementary Table I
- (R)-Enantiomer on Atherosclerotic Lesions Induced in Hypercholesterolemic Rabbits
- Flufenamic Acid-Loaded Self-Nanoemulsifying Drug Delivery
- Gastroretentive Pulsatile Release Tablets of Lercanidipine Hcl: Development, Statistical Optimization, and in Vitro and in Vivo Evaluation
- Pdf [Cited 2015 Jul 1] 2010;15:249-63
- Bioavailability Enhancement of Poorly Water-Soluble Drugs Via Nanocomposites: Formulation–Processing Aspects and Challenges
- Lercanidipine Hcl 10 Mg Film-Coated Tablets Lercanidipine Hcl 20 Mg Film-Coated Tablets Lercanidipine Hydrochloride
- Anti-Inflammatory Activity of Calcium Channel Blocker Lercanidipine Hydrochloride
- Interactions with Experimental COVID-19 Antiviral Therapies
- Calcium Channel Blockers (Dihydropyridine Derivatives) for the Treatment of Hypertension and Stable Angina
- Product Information – Australia APO-LERCANIDIPINE TABLETS
- WEB ANNEX J. TABLE of DRUG INTERACTIONS with ANTIRETROVIRAL DRUGS In: Updated Recommendations on First-Line and Second-Line Anti
- Supplementary Table 1 As Described in the Methods Section, for Every Medication, Odds Ratios
- Medicines Q&As
- Choosing a Drug from Within a Class
- A High Sensitive Quantification Method for Lercanidipine and Enalapril in Bulk and Pharmaceutical Formulations Using UHPLC/ESI-Q-TOF-MS
- MHRA Recommendations on Simvastatin Interactions: What Are the Implications for Patients Taking Amlodipine?
- Lecalpin 10 Mg Film-Coated Tablets Lecalpin 20 Mg Film-Coated Tablets Lercanidipine Hydrochloride
- 6004365) Date: 10 09 20, 03 12 20, 17 12 20 Artwork No
- Uva-DARE (Digital Academic Repository)
- Antiepileptic Drug Interactions